TY - JOUR AU - Bonadonna, G. AU - Molterni, A. AU - Zambetti, M. AU - Daidone, M. G. AU - Pilotti, S. AU - Gianni, L. AU - Valagussa, P. PY - 2005 DA - 2005// TI - 30 years' follow up of randomized studies of adjuvant CMF in operable breast cancer: cohort study JO - BMJ VL - 330 UR - https://doi.org/10.1136/bmj.38314.622095.8F DO - 10.1136/bmj.38314.622095.8F ID - Bonadonna2005 ER - TY - JOUR PY - 1998 DA - 1998// TI - Polychemotherapy for rearly breast cancer JO - Lancet VL - 352 UR - https://doi.org/10.1016/S0140-6736(98)03301-7 DO - 10.1016/S0140-6736(98)03301-7 ID - ref2 ER - TY - JOUR AU - Bonadonna, G. AU - Zambetti, M. AU - Gianni, L. AU - Valagussa, P. PY - 2004 DA - 2004// TI - Clinical relevance of different sequencing of doxorubicin and cyclophosphamide, methotrexate, and fluorouracil operable breast cancer JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.07.190 DO - 10.1200/JCO.2004.07.190 ID - Bonadonna2004 ER - TY - JOUR AU - Fisher, B. PY - 1992 DA - 1992// TI - The evolution of paradigms for the management of breast cancer: a personal perspective JO - Cancer Res VL - 52 ID - Fisher1992 ER -